Twitter timeline

Promising clinical results for innovative mutated anti-EGFR radiotracer in patients with non-small cell lung cancer

December 18, 2017

  • First stage of Phase 1 clinical study completed with promising results
  • Launch of second stage to evaluate the specificity of the radiotracer
  • Full study results expected in H1 2018